statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Discover Novartis' Q1 EPS soars 17% to $1.80, surpassing estimates. Sales hit $11.83B, up 10%. Entresto sales surge 36%, Cosentyx up 25%. CEO Vas Narasimhan bullish on mid & long-term growth.
read...

Novartis Stock Gains On European Drugmaker's Q1 Earnings Surprise, Lifts Annual Outlook

Novartis CEO: Broadly Positive About Business Momentum...

Novartis CEO: Broadly Positive About Business Momentum

Shares of Swiss drugmaker Novartis climbed 4.8% in early deals Tuesday after it raised its full-year guidance following better-than-expected first-quarter results...

Shares of Novartis climb 4.8% on raised guidance, better-than-expected results

Novartis Raises Guidance on Profit, Sales Growth...

Novartis Raises Guidance on Profit, Sales Growth

Key Events This Week: PCE, GDP, Fed Blackout And Earnings Gallore

 Hot on the heels of last week's tech and momentum rout, shaken traders will have to wait until Friday for the main...

Key Events This Week: PCE, GDP, Fed Blackout And Earnings Gallore

It's been a busy week for Swiss healthcare giant Novartis. In a series of days, the company said it's slowing trials of its blockbuster cancer drug and slashing hundreds of jobs and attempting to...

Novartis wants to buy a German cancer drugmaker as it stops recruiting for its own trials

Looking At Novartis's Recent Unusual Options Activity

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options...

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options

Futures On Edge Ahead Of Critical CPI Report

 Futures are up small before the March CPI data was expected to show further moderation in price pressures following stronger readings at the...

Futures On Edge Ahead Of Critical CPI Report

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Novartis announces new data on twice-yearly Leqvio in ASCVD

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Volume	1.56M
52-Wk High	$108.78
52-Wk Low	$88.90

NVS Novartis AG

About

Feed

News

Sentiment

Earnings

Fundamentals